Insider · CIK 0001769146
David Hession
Files at DORM (Dorman Products, Inc.). First filing Nov 3, 2025, latest Nov 3, 2025.
In brief
David Hession files SEC Form 4 as CFO at DORM (Dorman Products, Inc.). Since Nov 3, 2025, David Hession has reported 0 open-market buys worth $0 and 1 open-market sell worth $1.7M, the latest filed on Nov 3, 2025.
A track record needs three past buys with six months of prices behind them; David Hession has 0, so none is measured yet.
The newest scored trade: sold $1.7M of DORM on Oct 31, 2025, filed Nov 3, 2025, scored 67 (notable). In the last 12 months: 0 buys worth $0 and 1 sell worth $1.7M.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
DORM: Dorman Products, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 67Notable | DORMsell Dorman Products, Inc. | $1.7M 12,493 shares | -69% | +24% from low-19% from high |
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Oct 31, 2025 | DORM Dorman Products, Inc. | 12,493 0.04% of outstanding | $1.7M | Oct 31, 2025 | none |
Transactions
Every row this insider has filed, 11 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 19, 2026 | DORM Dorman Products, Inc. | AGrant or award Common Stock | +4,072 | $0.00 | $0 | 9,906 | Feb 23, 2026 |
| Feb 19, 2026 | DORM Dorman Products, Inc. | FTax withholding Common Stock | -1,889 | $127.73 | $241k | 8,017 | Feb 23, 2026 |
| Oct 31, 2025 | DORM Dorman Products, Inc. | SOpen-market sale Common Stock | -3,120 | $134.14 | $419k | 15,012 | Nov 3, 2025 |
| Oct 31, 2025 | DORM Dorman Products, Inc. | SOpen-market sale Common Stock | -6,515 | $135.42 | $882k | 8,497 | Nov 3, 2025 |
| Oct 31, 2025 | DORM Dorman Products, Inc. | SOpen-market sale Common Stock | -2,858 | $136.33 | $390k | 5,639 | Nov 3, 2025 |
| Mar 4, 2025 | DORM Dorman Products, Inc. | FTax withholding Common Stock | -492 | $130.25 | $64k | 18,132 | Mar 5, 2025 |
| Mar 2, 2025 | DORM Dorman Products, Inc. | FTax withholding Common Stock | -1,452 | $131.46 | $191k | 16,528 | Mar 4, 2025 |
| Mar 3, 2025 | DORM Dorman Products, Inc. | AGrant or award Common Stock | +2,096 | $0.00 | $0 | 18,624 | Mar 4, 2025 |
| Feb 20, 2025 | DORM Dorman Products, Inc. | AGrant or award Common Stock | +2,556 | $0.00 | $0 | 19,132 | Feb 24, 2025 |
| Feb 20, 2025 | DORM Dorman Products, Inc. | FTax withholding Common Stock | -1,152 | $126.49 | $146k | 17,980 | Feb 24, 2025 |
| Nov 19, 2024 | DORM Dorman Products, Inc. | GGift Common Stock | -370 | $0.00 | $0 | 16,451 | Nov 21, 2024 |
Questions about David Hession
Answered from the filings on this page, as of the latest one.
Is David Hession buying or selling?
In the last 12 months David Hession reported 0 open-market buys worth $0 and 1 open-market sell worth $1.7M on SEC Form 4; the latest was sold $1.7M of DORM on Oct 31, 2025. Grants, option exercises and tax withholding are not counted.
How did David Hession's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and David Hession has 0.
Where does David Hession file Form 4?
David Hession has filed Form 4 at DORM (Dorman Products, Inc.) as SVP and CFO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.